Will Gibbs

MANUAL delivers healthcare at scale thanks to its comprehensive digital clinic. Our ambition is to extend the healthy years of many lives in the UK, Brazil, and beyond focusing on life-impeding conditions like hormonal imbalance, obesity and hair loss. The company has steadily grown since inception, with $30m funding from leading investors, were now serving 500k+ patients, across 2 geographies. We are centralising the diagnosis, custom medications, doctor specialist services, behavioural change, and fully vertically integrated management of the treatment journey, under one roof. Innovating on healthcare delivery, MANUAL provides patients with engaging treatment plans generating superior clinical outcomes: 90%+ of patients see an improvement in their Quality of Life (QoL) within 6 months.

Our mission is to equip ADHD people with the skills and support they need to reach their full potential. Neurodiverse people deserve accessible, affordable, and effective care. Inflow is here to ease the pain of accessing support. Through a dynamic, science-based program, our members gain a better understanding of themselves, access coaching and practical tools, and learn strategies to manage their ADHD — all as part of a safe / stigma-free, accepting community.

LVNDR is a fully remote digital health service providing holistic healthcare for LGBTQ+ people to access care remotely including text/video consultations, testing, medication and support. We empower users to take control of their health with greater access to tailored services and features designed to fit their needs.

Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, lifesaving treatments. By fully automating and standardizing CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing. So complex manufacturing challenges can be put where they belong – in the past.

Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology. Pathologists are challenged to provide accurate and timely cancer diagnoses as their workloads keep increasing due to a rise in cancer prevalence and advances in personalized medicine that result in growing diagnostic complexity. We use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist. Our platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers eliminate diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity. Deployed worldwide, Ibex is the first-ever AI-powered cancer diagnostics platform used in routine clinical practice in pathology labs, with demonstrated success in improving the quality and efficiency of cancer diagnosis. We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: transform cancer diagnosis with AI and improve patient care. If you are an outstanding professional constantly looking for challenges, passionate about your work, a team player and want to make real impact – we want to hear from you.

Pelago is the world’s leading virtual clinic for substance use management. We are transforming substance use support—from prevention to treatment—delivering education, management skills, and opportunities for positive change to members struggling with substance use, most commonly tobacco, alcohol, opioids, and cannabis. Our solution gives employers the means to offer on-demand, personalized support to workers seeking to live healthier lives. Pelago’s cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs deliver convenient, accessible, and effective support that seamlessly integrates with health plans, pharmacy benefit managers, and wellness platforms. Visit www.pelagohealth.com for more information.

Back in 2018, we realised there was a huge problem in the world of skincare: people dont just struggle with their skin – they struggle with how theyre supposed to deal with it. With no truly effective solutions out there, low confidence levels and high frustrations make it difficult for us to bring our best selves to the day ahead. We knew there had to be a better way to give everyones skin what it really needed. So, with a small (but growing) team of dermatologists, pharmacists, direct-to-consumer experts and other brilliantly innovative people, we decided to change the face of skincare. And so, here we are – on a mission to build an accessible way for people to tackle their skin goals once and for all, with powerful, personalised solutions that truly work. Start tackling your skin goals with our free online dermatology consultation and sign up with the code LINKEDIN24 to get your first Daily Doser for £4.99✨

Depop is the community-powered fashion marketplace where anyone can buy, sell and discover desirable, affordable secondhand fashion. With over 35 million registered users, we’re on a mission to make fashion circular - encouraging more people to choose secondhand and extend the lives of their clothes, redefining fashion consumption. We believe that the secret to making fashion more circular - at scale - is by offering the most inspiring and accessible alternative to new, making it easy for people to choose resale over retail. Sitting at the intersection of style, value, and sustainability, we want Depop to be the most exciting place for anyone to engage with fashion and trends in a more circular way. Powered by a team of over 400 people, our company is headquartered in London, with offices in New York and Manchester. In 2021, Depop became a wholly-owned subsidiary of Etsy - the global marketplace for unique and creative goods - and continues to operate as a standalone company. Depop is an equal opportunity employer. We encourage individuals from underrepresented communities to apply, and collaborate with our Talent Team to ensure broader outreach. We celebrate diversity and are committed to creating an inclusive environment for all employees. We’re continuing to build recruitment processes that are fair and welcome requests for reasonable adjustments required throughout your interview experience with us. Depop supports visa sponsorship, sponsorship opportunities may be limited to certain roles and skillsets.

We show the possibility of plants through flavour, cooking expertise and everyday ease

Patch helps you discover the best plants for your space, delivers them to your door and helps you look after them.

Our mission is to support accountants and their clients with funding solutions. Intelligent Cashflow by Fluidly is closing, but our commitment to our partners remains. We partner with over 1,000 accountancy firms across the country to provide bespoke funding solutions for their ambitious clients. With our transition into OakNorth Bank, we can now offer funding from £250k up to tens of millions. Enquire about becoming a partner by emailing partnerships@oaknorth.co.uk

CHRONEXT (https://www.chronext.com) is the premier e-commerce destination for luxury watches. We have already served over 100,000 satisfied customers worldwide thanks to our vast selection of immediately available watches. We combine the best of both worlds by providing our customers with the opportunity to shop online and at our physical CHRONEXT Lounges. In doing so, we are reshaping the way luxury watches are bought and sold today. With our offices in Cologne, Zug, Hong Kong, and more, we have established CHRONEXT worldwide and continue to grow. The people who work for us are just as international as our worldwide presence. Almost 30 nationalities with various cultural backgrounds make up the CHRONEXT team differentiated to global entities. You can find out more about us here: https://www.chronext.com/about-us. Authenticity is a CHRONEXT pillar not only in terms of luxury watches but also our employees. We are always looking for smart and motivated people to join our team. Would you like to be a part of our team? Then please apply online via our career page: https://chronext.com/careers

Permutive puts publishers in control of their revenue by enabling them to reach and monetize 100% of their audience while respecting consumer privacy. With Permutive, publishers can develop unique audience insights, optimize campaigns on the fly, and provide detailed mid- and post-campaign reports. In unlocking the true value of their audience, Permutive’s customers drive direct deals, win more RFPs, and secure repeat business with advertisers. Permutive is trusted by the world’s largest publishers, including News Corp, Hearst, The Washington Post, BuzzFeed, Penske Media, Future plc, the BBC, The Guardian, Vox Media, Insider, Hubert Burda Media, Condé Nast International, Trusted Media Brands, Hello! and Reworld Media.

BehavioSec®, now LexisNexis® BehavioSec®, is the industry pioneer and technology leader for behavioral biometrics. We deliver actionable behavioral identity insight so businesses can provide customer-first digital experiences. Our behavioral biometrics technology helps passively establish identity trust and proactively target fraud as a transaction is happening. Find out more by visiting us at: https://risk.lexisnexis.com/

Seedcamp is a European seed fund, investing early in founders building the companies that define the next decade. Since 2007, Seedcamp has written the first check into more than 500 companies across Europe and beyond, including Revolut, Wise, UiPath, Synthesia and Fluidstack. Seedcamps seven-person investment team backs founders from first check through Series B and beyond, with a transatlantic presence spanning London and New York.

MANUAL delivers healthcare at scale thanks to its comprehensive digital clinic. Our ambition is to extend the healthy years of many lives in the UK, Brazil, and beyond focusing on life-impeding conditions like hormonal imbalance, obesity and hair loss. The company has steadily grown since inception, with $30m funding from leading investors, were now serving 500k+ patients, across 2 geographies. We are centralising the diagnosis, custom medications, doctor specialist services, behavioural change, and fully vertically integrated management of the treatment journey, under one roof. Innovating on healthcare delivery, MANUAL provides patients with engaging treatment plans generating superior clinical outcomes: 90%+ of patients see an improvement in their Quality of Life (QoL) within 6 months.

Our mission is to equip ADHD people with the skills and support they need to reach their full potential. Neurodiverse people deserve accessible, affordable, and effective care. Inflow is here to ease the pain of accessing support. Through a dynamic, science-based program, our members gain a better understanding of themselves, access coaching and practical tools, and learn strategies to manage their ADHD — all as part of a safe / stigma-free, accepting community.

LVNDR is a fully remote digital health service providing holistic healthcare for LGBTQ+ people to access care remotely including text/video consultations, testing, medication and support. We empower users to take control of their health with greater access to tailored services and features designed to fit their needs.

Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, lifesaving treatments. By fully automating and standardizing CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing. So complex manufacturing challenges can be put where they belong – in the past.

Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology. Pathologists are challenged to provide accurate and timely cancer diagnoses as their workloads keep increasing due to a rise in cancer prevalence and advances in personalized medicine that result in growing diagnostic complexity. We use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist. Our platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers eliminate diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity. Deployed worldwide, Ibex is the first-ever AI-powered cancer diagnostics platform used in routine clinical practice in pathology labs, with demonstrated success in improving the quality and efficiency of cancer diagnosis. We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: transform cancer diagnosis with AI and improve patient care. If you are an outstanding professional constantly looking for challenges, passionate about your work, a team player and want to make real impact – we want to hear from you.